Bayland Capital is a leading investment firm with a focus on innovative life science companies globally.
Bayland Capital is a leading investment firm with a focus on innovative life science companies globally.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Jan 12, 2023
LePure Biotech
|
Series C | — | Biopharma | — |
Aug 26, 2022
Lab Direct
|
Series A | $10M | Medical | — |
Nov 5, 2021
Wuxi Biortus Biosciences
|
Series B | ¥200M | Biotechnology | Yes |
Nov 13, 2020
Wuxi Biortus Biosciences
|
Series A | $15M | Biotechnology | Yes |